In addition, Amarantus
has completed various licenses and exclusive option agreements with leading universities to therapeutic applications for MANF in ophthalmology, diabetes and various undisclosed indication-specific therapeutic applications.
It's important for the military to get access to a product like this because the military is putting its soldiers in harm's way," said Gerald Commissiong, president and CEO of Amarantus
is uniquely positioned to improve both the diagnosis and treatment of Alzheimer's disease.
Generex said Tuesday it would license its RapidMistT technologies to Amarantus
, a California biotechnology company, in a $10 million deal including Amarantus
We are continuing to discuss partnership opportunities with Amarantus
and look forward to collaborating further in 2013.
In addition to skin substitute therapies; rare disease & conditions, human genetics, cystic fibrosis and cancer immunotherapy advancements are leading the biotech sector led by Amarantus
Bioscience Holdings, Inc.
OTCBB: RBCC) joint venture target Amarantus
30, 2015 /PRNewswire/ -- Amarantus
BioScience Holdings, Inc.
Representatives from top pharma, medical device and biotech companies as well as CROs led presentations and case studies including Nestle, ClinTec International, Isis Pharmaceuticals, inVentiv Health, Biosense Webster, Janssen, Amarantus
BioScience, Cerbomed, and others.
One of the most exciting developments this year was the deepening relationship between our company and Amarantus
For our latest commentary on Amarantus
and other trading plays like this click here.
OTCBB: RBCC) nears a new joint venture agreement to commercialize advances made by Amarantus
BioSciences (OTCBB: AMBS), the company's latest target continues to seek out additional investment capital from high-profile investors.